Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 6, 2010, Pages 1410-1412

  Tripodi, A ^a   Baglin, T ^b   Robert, A ^c   Kitchen, S ^d   Lisman, T ^e   Trotter, J F ^f  

^a UNIVERSITY OF MILAN   (Italy)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; BILIRUBIN; BLOOD CLOTTING FACTOR 5; CARBOXYLASE; CREATININE; FIBRINOGEN; THROMBOPLASTIN;

CARBOXYLATION; CHRONIC LIVER DISEASE; DISEASE SEVERITY; HUMAN; INTERNATIONAL NORMALIZED RATIO; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTHROMBIN TIME; SCORING SYSTEM; VITAMIN K DEFICIENCY;

CALIBRATION; CHRONIC DISEASE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASES; PROTHROMBIN TIME;

EID: 77954529608     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03877.x     Document Type: Note

References (10)

1. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor liver. Gastroenterology 2003, 124:91-6.
2. Trotter JF, Brimhall B, Arjal R. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004, 10:995-1000.
3. Robert A, Chazouillères O. Prothrombin time in liver failure: time, ratio, activity percentage, or international ratio? Hepatology 1996, 24:1392-4.
4. van den Besselaar AMHP, Poller L, Tripodi A. Guidelines for thromboplastins and plasmas used to control oral anticoagulant therapy (1999). World Health Organ Tech Rep Ser 1999, 889:64-93.
5. Deitcher SR. Interpretation of the international normalised ratio in patients with liver disease. Lancet 2002, 359:47-8.
6. Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell'Era A, Sei C, Mannucci PM. The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 2007, 46:520-7.
7. Bellest L, Eschwege V, Poupon R, Chazoullieres O, Robert A. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology 2007, 46:528-34.
8. Sermon AM, Smith JM, Maclean R, Kitchen S. INR in liver disease: an ISI derived from liver disease patients improves agreement between INRs with different reagents. Thromb Haemost 2010, 103:757-65.
9. Riddell AF, Calvaruso V, Tuddenham EG, Burroughs A, Gatt A. A pragmatic approach for the measurement of the INR in liver patients. J Thromb Haemost 2009, 7(Suppl. 2). abstract 106
10. Tripodi A, Chantarangkul V, Primignani M, Dell'Era A, Clerici M, Iannuzzi F, Aghemo A, Cazzaniga M, Salerno F, Mannucci PM. Point-of-Care Coagulation Monitors Calibrated for the International Normalized Ratio for Cirrhosis (INRliver) Can Help to Implement the INRliver for the Calculation of the MELD Score. J Hepatol 2009, 51:288-95.